Archive
1207331 B.C. Ltd. Announces Completion of the Arrangement with Canam Biotech Inc. and Issuance of Shares
Vancouver, B.C., November 18, 2026 – TheNewswire - 1207331 B.C. Ltd. (“331” or the “Company”) is pleased to announce that as a result of the completion of a plan of arrangement between the Company and CANAM BIOTECH INC. (formerly, HemaGenetics Technologies Corp.) (“CANAM”) under a plan of arrangement pursuant to an arrangement agreement (the “Arrangement”) entered into on July 9, 2019 between the Issuer, CANAM, 1207326 B.C. Ltd., 1207334 B.C. Ltd., 1207335 B.C. Ltd., 1207378 B.C. Ltd., 1207380 B.C. Ltd., 1207382 B.C. Ltd.,1208614 B.C. Ltd., 1208616 B.C. Ltd., 1209629 B.C. Ltd., 1209631 B.C. Ltd., 1210352 B.C. Ltd., and 1211319 B.C. Ltd., the Company became a reporting issuer in the provinces of Alberta and British Columbia, and pursuant to the Arrangement, 331 through the issuance of 551,636 common shares, subject to rounding down for any fractional shares, effective as of November 16, 2026 to eligible CANAM shareholders of record as of November 4, 2026, who are entitled to receive shares under the Arrangement. 331’s CUSIP number is “68266A103” and its ISIN number is “CA68266A1030”.
The Arrangement received CANAM Shareholder approval on August 9, 2019 and final court approval from the British Columbia Supreme Court under Part 9, Division 5 of the Business Corporations Act (British Columbia) on August 27, 2019. Further information regarding the Arrangement can be found on CANAM’s SEDAR+ profile at https://sedarplus.ca. Under the Arrangement, the record and effective date for the Arrangement can be set separately as between CANAM and each of the other parties to the Arrangement. Pursuant to the Arrangement, the effective date for the Arrangement as between CANAM and 331 was set for November 16, 2026.
331 was incorporated on May 2, 2019, and its fiscal year end is June 30th.
For further information please contact:
J. Scott Munro, Director
E-mail: admin@munrofinancial.ca
Forward-Looking Information: This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of 331. Forward-looking information is based on certain key expectations and assumptions made by the management of 331. Although 331 believes that the expectations and assumptions on which such forward-looking information is based on are reasonable, undue reliance should not be placed on the forward-looking information because 331 can give no assurance that they will prove to be correct. Forward-looking statements contained in this press release are made as of the date of this press release. 331 disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.